Carcinoma, Papillary, Follicular
Showing 26 - 50 of 9,381
A Gene Hunting Study for Familial Papillary Thyroid Cancer
Recruiting
- Thyroid
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Oct 13, 2022
Papillary Thyroid Microcarcinoma Trial in Los Angeles (Active Surveillance)
Recruiting
- Papillary Thyroid Microcarcinoma
- Active Surveillance
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jul 5, 2022
Studies on Tumors of the Thyroid
Recruiting
- Hurthle Cell Thyroid Cancer
- +4 more
- 68-Gallium Dotatate
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Cross-sectional Case and Control Study on Quality of Life,
Recruiting
- Papillary Thyroid Carcinoma
- Thyroid Cancer
- Thyroid lobectomy via trans-axillary approach
- Thyroid lobectomy via open approach
-
Beijing, Beijing, ChinaDepartment of General Surgery, Peking Union Medical College Hosp
Jul 5, 2023
Thyroid Tumors Trial in Lexington (Lenalidomide)
Completed
- Thyroid Neoplasms
-
Lexington, KentuckyUniversity of Kentucky Markey Cancer Center
May 28, 2020
Papillary Thyroid Carcinoma Trial in Guangzhou (retro-auricular single-site endoscopic thyroidectomy, traditional open surgery
Recruiting
- Papillary Thyroid Carcinoma
- retro-auricular single-site endoscopic thyroidectomy
- traditional open surgery thyroidectomy
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Apr 17, 2022
Papillary Renal Cell Carcinoma Type 2 Trial in France (Axitinib Oral Tablet [Inlyta], Pembrolizumab Injection [Keytruda])
Recruiting
- Papillary Renal Cell Carcinoma Type 2
- Axitinib Oral Tablet [Inlyta]
- Pembrolizumab Injection [Keytruda]
-
Angers, France
- +11 more
Aug 26, 2022
Papillary Thyroid Microcarcinoma, Thyroid, Thyroid Cancer Trial in New York (Percutaneous Laser Ablation (PLA))
Recruiting
- Papillary Thyroid Microcarcinoma
- +2 more
- Percutaneous Laser Ablation (PLA)
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 14, 2022
Thyroid Cancer Trial (Endoscopic surgery;)
Not yet recruiting
- Thyroid Cancer
- Endoscopic surgery;
- (no location specified)
Jun 30, 2022
Refractory Differentiated Thyroid Gland Carcinoma, Refractory Thyroid Gland Follicular Carcinoma, Refractory Thyroid Gland
Completed
- Refractory Differentiated Thyroid Gland Carcinoma
- +4 more
- Cediranib
- +3 more
-
Duarte, California
- +32 more
Jun 24, 2021
Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)
Available
- Clear Cell Kidney Cancer
- +2 more
- Axitinib 5 MG
- (no location specified)
Jul 3, 2023
Thyroid Cancer Trial in Suita (Targeted alpha therapy)
Recruiting
- Thyroid Cancer
- Targeted alpha therapy
-
Suita, JapanOsaka University Hospital
Mar 2, 2022
Predict Central Lymphnode Metastasis in Thyroid Papillary
Completed
- Thyroid Papillary Carcinoma
- male
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital of Sun Yat-Sen University
Dec 29, 2021
Papillary Thyroid Carcinoma Trial in Guangzhou (Retro-Auricular Single-Site Endoscopic Thyroidectomy, Transoral Endoscopic
Recruiting
- Papillary Thyroid Carcinoma
- Retro-Auricular Single-Site Endoscopic Thyroidectomy
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Mar 6, 2023
Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston
Recruiting
- Malignant Thyroid Gland Neoplasm
- +6 more
- Quality-of-Life Assessment
- +3 more
-
Ann Arbor, Michigan
- +1 more
Jan 24, 2023
Renal Clear Cell Carcinoma, Renal Papillary Cell Carcinoma Trial in London (Savolitinib, MEDI4736, Tremelimumab)
Active, not recruiting
- Renal Clear Cell Carcinoma
- Renal Papillary Cell Carcinoma
- Savolitinib
- +2 more
-
London, United KingdomThomas Powles
Aug 10, 2022
Radioiodine Planar andSPECT/CT Imaging With Iodine-123 for
Recruiting
- Thyroid Gland Follicular Carcinoma
- Computed Tomography
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Drainage, Thyroid Cancer Trial in Hangzhou (no drainage tube applied)
Recruiting
- Drainage
- Thyroid Cancer
- no drainage tube applied
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital School of Medicine Zhejiang Universit
Jun 19, 2022
RFA Treatment for Papillary Thyroid Microcarcinoma
Recruiting
- Papillary Thyroid Microcarcinoma
- Radiofrequency Ablation
-
New York, New YorkColumbia University
Dec 28, 2021
Kidney Cancer Trial run by the NCI (INC280)
Completed
- Kidney Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 18, 2021
Non-Medullary Thyroid Carcinoma Trial (Digoxin tablet)
Not yet recruiting
- Non-Medullary Thyroid Carcinoma
- Digoxin tablet
- (no location specified)
Aug 20, 2022
Metastatic Papillary Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial (Atezolizumab, Cabozantinib S-malate)
Recruiting
- Metastatic Papillary Renal Cell Carcinoma
- Stage IV Renal Cell Cancer AJCC v8
- Atezolizumab
- +4 more
-
Sacramento, California
- +38 more
Jan 17, 2023
Papillary Thyroid Microcarcinoma Trial in Hong Kong (Echopulse)
Suspended
- Papillary Thyroid Microcarcinoma
- Echopulse
-
Hong Kong, Hong KongQueen Mary Hospital
May 17, 2022
Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma Trial in Duarte
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +11 more
- Cabozantinib S-malate
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 22, 2022
RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun
Not yet recruiting
- RET-altered Non Small Cell Lung Cancer
- +3 more
-
Chang chun, Jilin, ChinaJinlin Province Cancer Hosipital
Dec 21, 2022